Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Preferred Stock Liabilities (2020 - 2021)

iSpecimen has reported Preferred Stock Liabilities over the past 2 years, most recently at $8.0 million for Q1 2021.

  • For Q1 2021, Preferred Stock Liabilities changed N/A year-over-year to $8.0 million; the TTM value through Mar 2021 reached $8.0 million, changed N/A, while the annual FY2020 figure was $11.2 million, N/A changed from the prior year.
  • Preferred Stock Liabilities for Q1 2021 was $8.0 million at iSpecimen, down from $11.2 million in the prior quarter.
  • Over five years, Preferred Stock Liabilities peaked at $11.2 million in Q4 2020 and troughed at $561041.0 in Q3 2020.